$106.10
0.00%
NYSE, Aug 30, 01:00 am CET
ISIN
US98956P1021
Symbol
ZBH

Zimmer Biomet Holdings, Inc. Stock price

$106.10
+11.15 11.74% 1M
+1.78 1.71% 6M
+0.47 0.44% YTD
-8.57 7.47% 1Y
-1.52 1.41% 3Y
-30.57 22.37% 5Y
+5.63 5.61% 10Y
+26.65 33.54% 20Y
NYSE, Closing price Fri, Aug 29 2025
+1.04 0.99%

Key metrics

Basic
Market capitalization
$21.2b
Enterprise Value
$28.2b
Net debt
$7.0b
Cash
$556.9m
Shares outstanding
197.9m
Valuation (TTM | estimate)
P/E
25.6 | 12.9
P/S
2.7 | 2.5
EV/Sales
3.6 | 3.4
EV/FCF
23.7
P/B
1.7
Dividends
DPS
$0.96
Yield 1Y | 5Y
0.9% | 0.8%
Growth 1Y | 5Y
0.0% | 0.6%
Payout 1Y | 3Y
21.7% | 27.7%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$7.8b | $8.3b
EBITDA
$2.1b | $2.9b
EBIT
$1.5b | $2.2b
Net Income
$823.4m | $1.6b
Free Cash Flow
$1.2b
Growth (TTM | estimate)
Revenue
4.1% | 8.2%
EBITDA
0.8% | 34.4%
EBIT
-1.6% | 43.6%
Net Income
-17.4% | 80.3%
Free Cash Flow
43.8%
Margin (TTM | estimate)
Gross
71.1%
EBITDA
27.1% | 34.8%
EBIT
19.3%
Net
10.5% | 19.6%
Free Cash Flow
15.2%
Financial Health
Equity Ratio
58.4%
Return on Equity
7.3%
ROCE
7.5%
ROIC
6.3%
Debt/Equity
0.6
More
EPS
$4.2
FCF per Share
$6.0
Short interest
4.0%
Employees
17k
Rev per Employee
$450.0k
Show more

Is Zimmer Biomet Holdings, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Zimmer Biomet Holdings, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

34 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast:

14x Buy
41%
18x Hold
53%
2x Sell
6%

Analyst Opinions

34 Analysts have issued a Zimmer Biomet Holdings, Inc. forecast:

Buy
41%
Hold
53%
Sell
6%

Financial data from Zimmer Biomet Holdings, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
7,834 7,834
4% 4%
100%
- Direct Costs 2,267 2,267
7% 7%
29%
5,567 5,567
3% 3%
71%
- Selling and Administrative Expenses 2,997 2,997
5% 5%
38%
- Research and Development Expense 444 444
1% 1%
6%
2,126 2,126
1% 1%
27%
- Depreciation and Amortization 617 617
7% 7%
8%
EBIT (Operating Income) EBIT 1,508 1,508
2% 2%
19%
Net Profit 823 823
17% 17%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Zimmer Biomet Holdings, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zimmer Biomet Holdings, Inc. Stock News

Neutral
PRNewsWire
5 days ago
Dr. Jonathan M. Vigdorchik Named Chief Medical Technology Advisor, Adult Reconstruction and Hip Implants Dr. Anand M.
Neutral
PRNewsWire
6 days ago
WARSAW, Ind. , Aug. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2025.
Neutral
PRNewsWire
8 days ago
WARSAW, Ind. , Aug. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the Annual Morgan Stanley Healthcare Conference on Monday, September 8, 2025, at 8:30 a.m.
More Zimmer Biomet Holdings, Inc. News

Company Profile

Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

Head office United States
CEO Ivan Tornos
Employees 17,000
Founded 1927
Website www.zimmerbiomet.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today